Page last updated: 2024-09-03

3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide and n-n-propylnorapomorphine

3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide has been researched along with n-n-propylnorapomorphine in 1 studies

Compound Research Comparison

Studies
(3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide)
Trials
(3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide)
Recent Studies (post-2010)
(3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide)
Studies
(n-n-propylnorapomorphine)
Trials
(n-n-propylnorapomorphine)
Recent Studies (post-2010) (n-n-propylnorapomorphine)
1406274412

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dolbeare, K; Gupta, SK; Johnson, RL; Mishra, RK; Pontoriero, GF1

Other Studies

1 other study(ies) available for 3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide and n-n-propylnorapomorphine

ArticleYear
Iso-lactam and reduced amide analogues of the peptidomimetic dopamine receptor modulator 3(R)-[(2(S)-pyrrolidinylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide.
    Bioorganic & medicinal chemistry, 2003, Sep-01, Volume: 11, Issue:18

    Topics: Animals; Apomorphine; Cattle; Cell Membrane; Corpus Striatum; Dopamine Agents; In Vitro Techniques; Lactams; Molecular Mimicry; Protein Binding; Pyrrolidinones; Radioligand Assay; Receptors, Dopamine; Structure-Activity Relationship

2003